Summary:
Click image to enlargeWe are looking for adults ages 18–80 who have been diagnosed with fatty liver. The purpose of the SYNERGY-NASH Study is to evaluate the safety and effectiveness of the study drug tirzepatide
at resolving NASH over 52 weeks of treatment. Individuals with fatty liver will be evaluated to determine if they have NASH and their eligibility to participate in the study. Each patient who qualifies will receive either the study drug or the placebo, as well as study-related medical exams, studyrelated laboratory tests, and lifestyle counseling, all at no cost. Compensation for travel may also be available
Qualified Participants Must:
• Be 18 years or older
•
Come to the clinic between New Patient Hours: Monday-Friday between 6:30am to 10am.
•
Must come fasting, bring a picture identification and medication bottles or a list of medications if taking any.
Qualified Participants May Receive:
Each patient who qualifies will receive either the study drug or the placebo, as well as study-related medical exams, studyrelated laboratory tests, and lifestyle counseling, all at no cost.
Compensation for travel may also be available.